An update on the management of Chagas cardiomyopathy

Authors: Rocha, Manoel OC; Teixeira, Mauro M; Ribeiro, Antonio L

Source: Expert Review of Anti-Infective Therapy, Volume 5, Number 4, August 2007 , pp. 727-743(17)

Publisher: Expert Reviews

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, infects nearly 18 million people in Latin America and mainly affects the heart, causing heart failure, arrhythmias, heart block, thromboembolism, stroke and death. In this review, the clinical diagnosis and management of Chagas cardiomyopathy are discussed. Particular emphasis is placed on the clinical staging of patients and the use of various diagnostic tests that may be useful in individualizing treatment of the two most relevant clinical syndromes, that is, heart failure and arrhythmias. The relevance of specific treatments are discussed, stressing the important role of parasite persistence in disease pathogenesis. We also discuss new therapy modalities that may have a role in the treatment of Chagas cardiomyopathy.

Keywords: arrhythmia; benznidazole; carvedilol; Chagas disease; heart block; heart failure

Document Type: Research article

DOI: 10.1586/14787210.5.4.727

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$73.00 plus tax Refund Policy